内页大图
Home > News > News
[Animal Modeling Drug Efficacy Evaluation] - Rhesus Monkey HGV Infection Model

[Animal Modeling Drug Efficacy Evaluation] - Rhesus Monkey HGV Infection Model

Experimental rhesus monkeys weighing 2.5-6.5kg and aged 2-8 years were selected. Prior to infection, ALT enzyme activity was detected to be normal, and liver biopsy showed no dynamic liver pathological changes...

2024-08-05
[Animal Modeling - Pharmacological Evaluation] - Model of Memory Consolidation Disorder Caused by Electric Shock

[Animal Modeling - Pharmacological Evaluation] - Model of Memory Consolidation Disorder Caused by Electric Shock

Wistar rats, weighing (216 ± 10) g; Instrument: Electroconvulsive device...

2024-08-05
[Animal Modeling - Pharmacological Evaluation] - Model of Memory Consolidation Disorder Caused by Brain Hypoxia

[Animal Modeling - Pharmacological Evaluation] - Model of Memory Consolidation Disorder Caused by Brain Hypoxia

mouse; Drug: a mixture of 96.2% N2 and 3.8% O2 gas, pure CO2, NaNO2; Instrument: a sealed jar...

2024-08-05
[Animal Modeling - Efficacy Evaluation] - Foot and Mouth Disease Virus Animal Model

[Animal Modeling - Efficacy Evaluation] - Foot and Mouth Disease Virus Animal Model

Dilute the foot-and-mouth disease virus ORMF8 with 0.01mol/L PBS (pH 7.4) to an LD50 of 10-3 to 10-7/0.2ml, and then inject each titer of virus solution intradermally through the hind limb toes of guinea pigs, with an injection dose of 0.2ml per anim...

2024-08-05
【Animal Modeling - Pharmacological Evaluation】 - Tree Shrew Hepatitis B Model

【Animal Modeling - Pharmacological Evaluation】 - Tree Shrew Hepatitis B Model

Tree shrews were inoculated via femoral vein with 0.5ml of serum from hepatitis B patients with positive hepatitis B B virus surface antigen (HBsAg) and hepatitis B B virus e antigen (HBeAg)...

2024-08-05
[Animal modeling - Drug efficacy evaluation] - Pulmonary heart disease

[Animal modeling - Drug efficacy evaluation] - Pulmonary heart disease

Select adult Japanese large eared rabbits and inject a 1% mass fraction of ferric chloride aqueous solution into the rabbit ear vein. Inject 0.5ml twice a week from week 1 to week 4; From the 5th to the 6th week, twice a week, 0.75ml each time; In th...

2024-08-05
[Animal Modeling - Pharmacological Evaluation]- Depression Models in Solitary or Separate Care

[Animal Modeling - Pharmacological Evaluation]- Depression Models in Solitary or Separate Care

Some primates or non primates may exhibit characteristic symptoms such as agitation, sleep disorders, and lamenting after separation from their offspring...

2024-08-05
[Animal Modeling Drug Efficacy Evaluation ]- Heymann Nephritis Model in Rats

[Animal Modeling Drug Efficacy Evaluation ]- Heymann Nephritis Model in Rats

rats, weighing 150-200g; Drug: Complete Freund\'s adjuvant, physiological saline...

2024-08-05
[Animal Modeling - Pharmacological Evaluation] - Ovarian Resection Induced Osteoporosis Animal Model

[Animal Modeling - Pharmacological Evaluation] - Ovarian Resection Induced Osteoporosis Animal Model

Primary osteoporosis includes postmenopausal osteoporosis and senile osteoporosis, mainly characterized by decreased bone mass, degeneration of bone microstructure, decreased bone strength and increased fragility, and susceptibility to fractures...

2024-08-02
[Animal Modeling - Pharmacological Evaluation] - Corticosteroid Induced Osteoporosis Animal Model

[Animal Modeling - Pharmacological Evaluation] - Corticosteroid Induced Osteoporosis Animal Model

The extensive use of glucocorticoids can cause calcium and phosphorus metabolism disorders in animal bodies, reduce the transformation of pre osteoblasts into functional osteoblasts, directly inhibit osteoblast function, reduce collagen synthesis, re...

2024-08-02
[Animal Modeling - Pharmacological Evaluation] - Allogeneic Bone Tumor Animal Model

[Animal Modeling - Pharmacological Evaluation] - Allogeneic Bone Tumor Animal Model

Allogeneic transplantation refers to the transplantation of the same or homologous animal species. The commonality between the donor and recipient is significant, making it easy to stay in the body, grow and reproduce, and reproduce the tumor process...

2024-08-02
Animal Modeling Drug Efficacy Evaluation Allergic Conjunctivitis Model

Animal Modeling Drug Efficacy Evaluation Allergic Conjunctivitis Model

Eye hypersensitivity is mainly a type I hypersensitivity reaction mediated by mast cells. Hay fever conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, and macromastic keratoconjunctivitis are mainly involved in type I allergic ...

2024-08-02
[Animal Modeling - Pharmacological Evaluation] - Corneal Injury Animal Model

[Animal Modeling - Pharmacological Evaluation] - Corneal Injury Animal Model

Corneal injury can be divided into damage to the corneal endothelium and damage to the corneal epithelium and stroma according to different levels...

2024-08-02
[Animal Modeling - Efficacy Evaluation] - Dry Eye Disease Animal Model

[Animal Modeling - Efficacy Evaluation] - Dry Eye Disease Animal Model

Dry eye disease, also known as dry keratoconjunctivitis, is one of the most common eye diseases, which can cause damage to the ocular surface and blurred vision, affecting the quality of life of patients...

2024-08-02
[Animal Modeling - Pharmacological Evaluation ]- Metabolic Cataract Animal Model

[Animal Modeling - Pharmacological Evaluation ]- Metabolic Cataract Animal Model

This type of cataract model forms cataracts by affecting the substance metabolism of the crystalline lens through various drugs, commonly used including D-galactose, sodium selenate, naphthalene, and glucocorticoids, as well as less commonly used dru...

2024-08-02
[Animal Modeling - Pharmacological Evaluation] - Chronic Epilepsy Animal Model

[Animal Modeling - Pharmacological Evaluation] - Chronic Epilepsy Animal Model

The chronic epilepsy model can reflect the initiation, development, and accompanying pathological and physiological changes in the brain during epileptic seizures. This provides a foundation for further research on epilepsy. According to the intensit...

2024-08-02